1. FRI0433 Nuclear Receptor NR4A1 as a Checkpoint of Physiological Wound Healing and Fibrosis. (9th June 2015) Authors: Palumbo-Zerr, K.; Zerr, P.; Distler, A.; Mancuso, R.; Huang, J.; Tomcik, M.; Scholtysek, C.; Dees, C.; Beyer, C.; Krönke, G.; Distler, O.; Schett, G.; Distler, J. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 584 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0435 Interleukin-35 is Overexpressed in Systemic Sclerosis and its Serum Levels are Elevated in Early Disease. (9th June 2015) Authors: Tomcik, M.; Zerr, P.; Palumbo-Zerr, K.; Storkanova, H.; Hulejova, H.; Spiritovic, M.; Kodet, O.; Stork, J.; Becvar, R.; Vencovsky, J.; Pavelka, K.; Filkova, M.; Distler, J.H.; Senolt, L. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 584 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0525 Poly(ADP-RIBOSE) Polymerase-1 (PARP-1) Suppresses the Profibrotic Effects of Transforming Growth Factor-β in Systemic Sclerosis. (10th June 2014) Authors: Zhang, Y.; Palumbo-Zerr, K.; Beyer, C.; Zerr, P.; Liang, R.; Dees, C.; Distler, O.; Schett, G.; Distler, J.H.W. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 577 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0016 Tribbles homolog 3 mediates the stimulatory effects of tgf-beta on fibroblast activation and dermal fibrosis in systemic sclerosis. (23rd January 2014) Authors: Tomcik, M.; Palumbo-Zerr, K.; Avouac, J.; Horn, A.; Khodzighorova, A.; Zerr, P.; Dees, C.; Distler, A.; Beyer, C.; Becvar, R.; Senolt, L.; Distler, O.; Schett, G.; Distler, J.H. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP0156 Epigenetic Silencing of Endogenous WNT Inhibitors Contributes to the Aberrant Activation of Canonical WNT Signaling in Systemic Sclerosis. (23rd January 2014) Authors: Dees, C.; Schlottmann, I.; Funke, R.; Distler, A.; Palumbo-Zerr, K.; Zerr, P.; Lin, N.-Y.; Beyer, C.; Distler, O.; Schett, G.; Distler, J. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0231 Heart involvement in scleroderma patients and mice models. (23rd January 2014) Authors: Venalis, P.; Kumánovics, G.; Schulze-Koops, H.; Akhmetshina, A.; Dees, C.; Zerr, P.; Cziriak, L.; Mackevic, Z.; Lundberg, I.E.; Distler, O.; Schett, G.; Distler, J.H. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OP0237 Twist1 Amplifies Canonical Tgf-Beta Signaling in Ssc. (10th June 2014) Authors: Palumbo-Zerr, K.; Liebl, A.; Zerr, P.; Distler, A.; Beyer, C.; Distler, O.; Schett, G.; Distler, J.H. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OP0240 Signal Transducer and Activator of Transcription 3 Regulates Fibroblast Activation as A Downstream Mediator of Transforming Growth Factor-Beta. (10th June 2014) Authors: Šumová, B.; Zerr, K.P.; Dees, C.; Zerr, P.; Distler, O.; Schett, G.; Senolt, L.; Distler, J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OP0267 Sirt1 Regulates Canonical Tgf-Beta Signaling to Control Fibroblast Activation and Tissue Fibrosis. (10th June 2014) Authors: Zerr, P.; Palumbo-Zerr, K.; Huang, J.; Distler, A.; Distler, O.; Schett, G.; Distler, J.H. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SAT0025 Antifibrotic effects of imatinib mesylate are not superior to selective inhibition of PDGFR by ARRY-768 in preclinical models of dermal fibrosis. (23rd January 2014) Authors: Tomcik, M.; Reich, N.; Palumbo-Zerr, K.; Zerr, P.; Avouac, J.; Distler, A.; Robinson, J.; Dees, C.; Beyer, C.; Becvar, R.; Senolt, L.; Distler, O.; Schett, G.; Distler, J.H. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 479 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗